<. Smithline is now in the drivers seat and dealing tough. If the shares are not authorized, the big hammer could fall. >
Unbelievable... Smithline, who could have taken over the assets several times since Dec last year just granted an extension until at least mid Feb, which might become effective for 3 years if the company raises more money and NOW you are saying that they are in the driver's seat? Give me a break...
What happened to all your predictions of what Smithline was going to do, the company going into Chapter, etc. Do you remember when you predicted that BOCX would be among the 50% of biotech startups that were not going to survive?
Where you wrong when you predicted all that? Answer that question, a simple yes or no...